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Borrmann type 4 gastric cancers are notorious for the difficulty of finding cancer cells in the biopsy samples obtained from gastrofibersco-
py. It is important to obtain the biopsy results for making surgical decisions. In cases with Borrmann type 4 gastric cancer, even though 
the radiological findings (such as an upper gastrointestinal series, abdominal computed tomography and positron emission tomography/
computed tomography) or the macroscopic findings of a gastrofiberscopy examination imply a high suspicion of cancer, there can be dif-
ficulty in getting the definite pathologic results despite multiple biopsies. In these cases, we have performed endoscopic mucosal resec-
tion under gastrofiberscopy as an alternative to simple biopsies. Here we report on a case in which no cancer cells were found even in 
the endoscopic mucosal resection specimen, but the radiologic evidence and clinical findings were highly suspicious for gastric cancer. 
The patient finally underwent total gastrectomy with lymph node resection, and she was pathologically diagnosed as having stage IV 
gastric cancer postoperatively.
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Introduction
Advanced gastric cancer is classified as the Borrmann types 
based on the characteristic macroscopic morphology. Among them, 
Borrmann type 4 gastric cancer is referred to as linitis plastica or 
scirrhous carcinoma, which has the characteristic of diffuse infil-
tration that occupies a large area of the stomach, serous infiltration 
and frequent lymph node metastasis.(1)
The primary lesions of Borrmann type 4 are different from 
other macroscopic types of gastric cancer as the former infiltrates 
the submucosal layer and the disease progress and specific find-
ings in the mucosa layer are not sufficient for making a diagnosis, 
and so making an early diagnosis is difficult. In addition, peritoneal 
metastasis is common at the time of its detection, and so therapeu-
tic resection is difficult and the prognosis is very poor.(2,3)
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Endoscopic gastric mucosal resection performed prior to surgery 
for making the diagnosis is a procedure that comprehensively ex-
amines the lesions endoscopically. It lifts the lesion by the submu-
cosal injection of a mixture of physiological saline, epinephrine and 
indigo carmine, and the mucosa is then resected. This procedure 
has recently been widely applied for the treatment of early gastric 
cancer. At our hospital, for a case that cancer cells could not be 
detected by repeated endoscopic biopsy, we performed histological 
tests on the endoscopically resected gastric mucosa, but cancer cells 
still could not be detected. Based on the radiological test findings, 
the endoscopic macroscopic characteristics and the characteristics 
of the clinical course, we performed total gastrectomy and lymph-
adenectomy. The tissues obtained from the surgery were examined, 
and the patient’s disease was determined to be Borrmann’s type 4 
gastric cancer.
Case Report
A 45 years old female was admitted for nausea, vomiting and 
anorexia, and this had all started 6 months previously. For her past 
history, she was diagnosed with hypertension 10 years ago, she 
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was diagnosed as having IgA nephropathy 5 years ago and she was 
taking beta-blocker, Cozaar and angiotensin converting enzyme 
inhibitors. There was no significant family history. The vital signs 
were normal at the time of admission. On the abdominal physi-
cal examination, a hard and mobile mass the size of a baby’s fist 
was palpated in the upper abdomen and this was associated with 
pain. Any other special findings were not detected on the physical 
examination. The results of the general blood tests that included 
tumor markers were all normal.
On gastroduodenoscopy, the mucosa of the body of the stomach 
was not well spread, and the gastric folds were thicker and harder 
than normal, and so we suspected this to be Borrmann’s type 4 
stomach adenocarcinoma that showed hypertrophic gastric lesions, 
and then a biopsy was performed (Fig. 1). On the abdominal com-
puted tomography, similarly, the layering of the stomach wall was 
lost and the pattern that the stomach was not well spread suggested 
linitis plastica corresponding to Borrmann’s type 4 stomach adeno-
carcinoma (Fig. 2). 
On gastroduodenoscopy and ultrasonography, the greater curva-
ture of the stomach wall showed diffuse thickening, and the thick-
ness was observed to be approximately 10 mm. Particularly, the 
2nd layer was thickened and heterogeneous low echo contrast was 
primarily seen, and these findings corresponded to hypertrophic 
gastric disease or type 4 advanced stomach cancer. When perform-
ing a gastroduodenal barium enema, we observed that the entire 
stomach wall was thickened and the stomach space was narrowed. 
In addition, there was the loss of peristaltic movement. 
Gastric cancer was suspected and so endoscopic biopsy per-
formed, but cancer cells were not detected. Nonetheless, several 
imaging findings and the clinical symptoms strongly suggested 
stomach cancer. Thus, endoscopic mucosal resection of the stom-
ach wall was performed for making the diagnosis (Fig. 3). After the 
mucosal resection of the hypertrophic lesions of the greater curva-
ture and the anterior wall of the body, tissues were taken by biopsy 
forceps from the area determined to be the submucosal layer and 
histological tests were performed. Nevertheless, cancer cells were 
not detected on the histological tests, and only the thickening of 
epithelial cells was observed (Fig. 4).
Stomach cancer was strongly suspected and surgery was rec-
ommended. However, the patient refused to undergo surgery with-
out a definite histological diagnosis. Ambulatory follow-ups were 
planned and the patient was discharged. During the follow-up  Fig. 1. Gastrofi  berscopy showing the hypertrophic gastropathy.
Fig. 2. Abdominal CT scan showing the encircling gastric wall thicken-
ing. Fig. 3. Endoscopic mucosal resection.Diagnosis of Borrmann Type 4 Gastric Cancer
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observation, the clinical symptoms of the patient deteriorated, and 
surgery was again recommended. The patient agreed to undergo 
surgery and laparotomy was performed. During laparotomy, adhe-
sion or ascites was not detected. In addition, there were no findings 
of metastasis to other organs within the abdominal cavity and the 
rectal shelf, and dissemination in the peritoneum was not observed. 
The stomach wall was thickened overall, and the local enlarge-
ment of lymph nodes in the vicinity of the stomach was observed, 
so total gastrectomy, extended lymphadenectomy and Roux-en-Y 
esophagojejunostomy were performed. The stomach disease was 
diagnosed as poorly differentiated type 4 advanced stomach cancer 
by the postsurgical pathohistological tests. The mucosa layer was 
thickened to 5~9 mm, and most of the cancer cells were found as 
a pattern that initiated from the submucosal layer and then it spread 
(Fig. 5). This was the diffuse type according to Lauren’s classifica-
tion. Tumor had penetrated and invaded the serous layer. Cancer 
cell metastasis was detected in 23 of the 35 resected lymph nodes 
and the final disease stage was determined to be stage IIIc (T4aN-
3bMo) according to the AJCC TNM staging system (7
th ed).
After surgery, the patient was discharged without any special 
complications. Combination chemotherapy with TS-1 and cisplatin 
was initiated from 4 weeks after surgery. However, anorexia and 
severe bone marrow suppression developed during the 4th cycle, 
and so currently, the chemotherapy has been interrupted and the 
patient is under ambulatory follow-up observation.
Discussion
The diagnosis of Borrmann’s type 4 stomach cancer, which is 
an advanced state of scirrhous carcinoma, is difficult, and so the 
diagnosis is often delayed due to false negative endoscopic and his-
tological tests. These tests can be negative because the characteristic 
of cancer cells that are in the area below the mucosa appears to be 
normal, and the cancer cells along the submucosal plane have an 
unclear boundary and they widely infiltrate into the vicinity. Kohli 
et al.(4) have reported that the initial endoscopic findings of Bor-
rmann’s type 4 stomach cancer may interpreted as the IIc type or 
III+IIc type, and these types have the macroscopic morphology of 
early stomach cancer. So, for making the diagnosis of Borrmann’s 
type 4 cancer, attention should be paid to the shallow depressions 
and slight stiffness of the stomach wall. It has been reported that 
abdominal computed tomography has 89% sensitivity for making 
the diagnosis of Borrmann’s type 4 stomach cancer, but it is not 
effective for making an early diagnosis.(5) 
Because early detection is difficult, tumor progression could 
readily induce disseminated metastasis in the peritoneum, and then 
the rate of lymphatic metastasis is high, and there are reports of 
peritoneal metastasis occurring even after therapeutic resection. 
Cytochemical or molecular studies on such a particular growth and 
progression pattern are now ongoing.(6,7)
Because of the biological characteristic of Borrmann’s type 4 
stomach cancer that it tends to spread to the peritoneum, perito-
neal metastasis is frequently detected at the time of diagnosis, and 
its prognosis is known to be poor. Nonetheless, clinicopathological 
Fig. 4. Th   ere were no cancer cells on the biopsy by endoscopic mucosal 
resection (H&E stain, ×100).
Fig. 5. Th   e tumor cells begin from the submucosal layer (H&E stain, 
×100).Ahn JB, et al.
62
factors that are significantly different from other types are associ-
ated with the disease stages in most cases, and these factors have 
been revealed to be closely associated with a delayed diagnosis. Be-
cause of a delayed diagnosis, already highly advanced disease stages 
are seen at the time of surgery and Borrmann’s type 4 stomach 
cancer occupies the entire stomach in many cases and it can not be 
resected, and so non-curiative resection is frequently performed. 
Therefore, it is thought that presurgical chemotherapy may be 
one possible method to obtain a good prognosis by lowering the 
disease stage and increasing the resection rate,(8) and prospective 
randomized studies on such methods are now ongoing. Postsurgical 
complications develop at a significantly higher rate in patients with 
Borrmann type 4 disease as compared with that of the other mac-
roscopic types of stomach cancer. This is thought to be due to that 
the frequency of combined resection of organs in the vicinity of 
stomach is high, the resection margin is positive for residual cancer 
in many cases and non-curative resection is performed in many 
cases.(1)
It has been reported that the characteristics of Borrmann’s type 
4 stomach cancer are the high frequency of undifferentiated car-
cinoma and the proliferation of interstitial cells.(1,9-11) Ichiyoshi 
et al.(12) have reported that such cancer cells primarily spread 
one dimensionally on the stomach wall and serous infiltration was 
overlooked in 40% of the cases when it was diagnosed macroscopi-
cally only during surgery, and then the opportunities to prevent 
peritoneal recurrence by intraperitoneal chemotherapy during sur-
gery were lost. Presently, the new oral derivatives of 5-fluorouracil 
TS-1 have shown higher than anticipated treatment effectiveness 
in clinical studies.(13)
There is a high rate of a false negative diagnosis of Borrmann’s type 
4 stomach cancer by performing abdominal computed tomography 
and other imaging methods, as well as by an endoscopic diagnosis. 
Therefore, it is thought that endoscopic gastric mucosal resection, as 
a new treatment method for early stomach cancer, may be of help 
to diagnosis Borrmann’s type 4 stomach cancer that is not clear on 
abdominal computed tomography or positron emission tomogra-
phy/computed tomography or to diagnose local Borrmann’s type 
4 stomach cancer. However, as was noted in our case, in stomach 
tissues with highly hypertrophic mucosa, if the spread of cancer 
cells is initiated from the submucosal layer, then obtaining a biopsy 
that includes the submucosal layer may be very difficult when per-
forming endoscopic stomach mucosal resection. The thickness of 
the stomach mucosal layer of our case was 5~9 mm, which was 2 
times thicker than the normal thickness (3~4 mm). Therefore, if 
Borrmann’s type 4 stomach cancer is strongly suspected prior to 
surgery and surgery is being considered, then deep resection of the 
stomach wall for obtaining the submucosal layer when perfoming 
endoscopic stomach mucosal resection may increase the diagnosis 
rate despite of the development of stomach perforation and com-
plications. 
Our patient was suspected to have Borrmann’s type 4 stomach 
cancer, the cancer cells could not be detected even on the biopsy 
by endoscopic stomach mucosal resection and so it was a difficult 
case. We were able to histologically diagnose the cancer after total 
gastrectomy, and lymphadenectomy performed because of the de-
terioration of the clinical course.
It is well known that making the definite presurgical histological 
diagnosis of Borrmann’s type 4 stomach cancer is difficult in many 
cases due to the characteristic development process of the tumor 
cells. For such cases, repeated endoscopic biopsy or deep biopsy 
that reaches the deep area of the stomach wall is required. For cases 
that cancer cells could not be detected despite of repeated biopsy, 
by considering the results of abdominal computed tomography, the 
upper gastrointestinal series and the clinical symptoms together, 
laparotomy can be decided on for many cases. In our case, cancer 
cells could not be detected despite perfoming 3 gastroscopic biop-
sies. Nonetheless, the findings of abdominal computed tomography, 
the upper gastrointestinal series and the clinical symptoms strongly 
suggested stomach cancer, and laparotomy was recommended to 
the patient. Yet the patient refused to undergo surgery without a 
definite histological diagnosis, so we performed stomach mucosal 
resection as an additional diagnostic method. Cancer cells could not 
be detected even with this procedure. However, the patient’s clinical 
symptoms deteriorated and then the patient consented to undergo 
surgery. However, the cost of endoscopic stomach wall mucosal 
resection is high, and it has problems of complications associated 
with the procedure (hemorrhage, perforation of stomach wall, 
etc.). Hence, it may be attempted for very specially selected cases 
of suspected Borrmann’s type 4 stomach cancer, for example, for 
suspected cases of local Borrmann’s type 4 stomach cancer, or for 
cases whose results of abdominal computed tomography or positron 
emission tomography/computed tomography are not clear. Biopsy 
by gastroscopic ultrasonography(14,15) and endoscopic submucosal 
dissection may be additional presurgical diagnosis methods.
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